Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults
Clinical trial NCT00380211 · COMPLETED
Trial details
- NCT number
- NCT00380211
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.